Telomeres Might Predict Lung Cancer Recurrence
Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.
One of the most pressing concerns for newly minted graduate students and post-doctoral trainees is how to secure an academic position -- or how to ready themselves for a non-academic career in industry, government, or other areas.
8/14/2014 | 0 comments
A new grant will allow UR researchers to focus on the basic mechanisms that apply to a broad spectrum of genetic and acquired heart rhythm disorders.
8/13/2014 | 0 comments
Aspirin has been called a wonder drug, but a new study shows that a majority of people eligible to take it as a preventive therapy don’t recall their doctors ever telling them to do so.
8/7/2014 | 1 comment
UR Pathology Professor David G. Hicks, M.D., a national leader in using molecular technology to diagnose breast cancer, helped to design a new tool to assist other U.S. pathologists in how to personalize treatment for patients with invasive disease.
7/31/2014 | 0 comments
Military troops take doxycycline to prevent infections and malaria, and teenagers use it to treat acne. Wilmot Cancer Institute scientists are also testing it for the treatment of lymphoma.
7/24/2014 | 0 comments